C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2011
12/15/2011	US20110305714 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
12/15/2011	US20110305712 Ctla4 proteins and their uses
12/15/2011	US20110305711 Cgrp antibodies
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305704 Antibody to cytolethal distending toxin of campylobacter jejuni
12/15/2011	US20110305703 Isolated vegf-c and vegf-d peptides and uses thereof
12/15/2011	US20110305702 Epitopes
12/15/2011	US20110305701 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
12/15/2011	US20110305697 Fc fusion proteins
12/15/2011	US20110305696 anti-serum albumin binding variants
12/15/2011	US20110305692 Antigen-binding contructs
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305688 New virulence factors of streptococcus pneumoniae
12/15/2011	US20110305687 Anti-fgfr2 antibodies
12/15/2011	US20110305686 Therapies for chronic renal failure using one or more integrin antagonists
12/15/2011	US20110305685 Supramolecular approach for preparation of size controllable nanoparticles
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	US20110305630 Misfolded proteins in cancer treatment and diagnosis
12/15/2011	CA2814155A1 Anti-tim-3 antibody
12/15/2011	CA2802102A1 Cgrp antibodies
12/15/2011	CA2802017A1 Dimeric vstm3 fusion proteins and related compositions and methods
12/15/2011	CA2801771A1 Sulfation of wnt pathway proteins
12/14/2011	EP2395026A2 Method for improving antibody
12/14/2011	EP2395025A1 Engineered Anti-IL-23R Antibodies
12/14/2011	EP2395024A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395023A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395022A1 Lingo binding molecules and pharmaceutical use thereof
12/14/2011	EP2395021A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
12/14/2011	EP2395020A2 IL-18 binding proteins
12/14/2011	EP2395019A1 Remedy for chronic inflammation and antibody to be used therein
12/14/2011	EP2395018A1 Human binding molecules having killing activity against staphylococci and uses thereof
12/14/2011	EP2395017A2 Design and use of paired variable regions of specific binding molecules
12/14/2011	EP2395016A2 Design and use of paired variable regions of specific binding molecules
12/14/2011	EP2394662A2 Methods and compositions for treating and preventing disease associated with AlphavBeta5 intergrin
12/14/2011	EP2394661A1 Sp35 antibodies and uses thereof
12/14/2011	EP2394660A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/14/2011	EP2394659A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
12/14/2011	EP2394658A2 Passive immunization against clostridium difficile disease
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2394652A2 Methods and compositions for treating tumors and metastatic disease
12/14/2011	EP2394173A2 Immunoglobulin glycosylation pattern analysis
12/14/2011	EP2394159A2 Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
12/14/2011	EP2393927A1 Production of oligoclonal mixtures of immunoglobulins in single cells
12/14/2011	EP2393923A1 Methods and compositions for treatment of neovascularization
12/14/2011	EP2393836A1 Sam-6 variants, target and methods of use
12/14/2011	EP2393835A2 Pd-1 antibodies and pd-l1 antibodies and uses thereof
12/14/2011	EP2393515A1 Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
12/14/2011	EP2393498A1 Cancer diagnosis and treatment
12/14/2011	EP2041177B1 High affinity antibodies to human il-6 receptor
12/14/2011	EP1943272B1 Novel cxc-chemokine antagonists
12/14/2011	EP1888641B1 Serum albumin binding proteins
12/14/2011	EP1740616B1 Anti-tfr antibody.
12/14/2011	EP1166121B1 Selection of intracellular immunoglobulins
12/14/2011	EP1085090B1 IgA NEPHROPATHY-ASSOCIATED DNA
12/14/2011	EP1005488B2 Receptor that binds trail
12/14/2011	CN1934133B 抗a型流感病毒单克隆抗体及使用该抗体的免疫测定器具 A anti-influenza A virus monoclonal antibodies and the use of the antibody immunoassay device
12/14/2011	CN102282174A 抗人epo受体的抗体 Epo receptor antibody against human
12/14/2011	CN102282173A 用于治疗骨丢失的方法和组合物 Methods for treating bone loss and compositions
12/14/2011	CN102282172A 抗伸展的Ⅰ型鞘糖脂抗体、其衍生物以及用途 Anti-stretch Ⅰ type glycosphingolipids antibodies, their derivatives and uses
12/14/2011	CN102282171A 抗基孔肯雅病毒单克隆抗体及其用途 Anti-Chikungunya virus monoclonal antibodies and their use
12/14/2011	CN102282170A 从浆细胞产生抗体的方法 The method of producing antibodies from plasma cells
12/14/2011	CN102279269A 胱抑素c检测剂盒的制备方法 Preparation cystatin c detection agent cartridge
12/14/2011	CN102279264A 48种恶性肿瘤标志物抗体芯片的制备方法 48 kinds of cancer marker antibody preparation chip
12/14/2011	CN102277334A 一种抗人蛋白rn181的单克隆抗体及杂交瘤细胞株3953与试剂盒 An anti-human monoclonal antibody and protein rn181 hybridoma cell lines and kits 3953
12/14/2011	CN102277333A 抗口蹄疫病毒的单克隆抗体及其识别的抗原表位和应用 Monoclonal anti-FMDV antibodies and recognize epitopes and applications
12/14/2011	CN102277332A 一种抗口蹄疫病毒的单克隆抗体及用途 An anti-FMD virus monoclonal antibodies and uses
12/14/2011	CN102276724A 抗cd37抗体 Anti-cd37 antibody
12/14/2011	CN102276723A 抗VEGF单克隆抗体Vancolizumab及其应用 Anti-VEGF monoclonal antibody and its application Vancolizumab
12/14/2011	CN102276722A 新型血管内皮生长因子人源化单克隆抗体 The new vascular endothelial growth factor humanized monoclonal antibody
12/14/2011	CN102276721A 一种用于肝癌血清学诊断的单克隆抗体及其用途 A serological diagnosis of liver cancer monoclonal antibodies and their use
12/14/2011	CN102276720A 一种高生物活性卵黄抗体及其制备方法 A highly bioactive yolk antibodies and methods
12/14/2011	CN102276719A 禽流感病毒单域抗体、五聚抗体及其制备和应用 Avian influenza virus single domain antibodies, antibody pentamer its preparation and application
12/14/2011	CN102276718A 水-辛酸两步法提取卵黄免疫球蛋白工艺 Water - the bitterness of a two-step extraction process yolk immunoglobulin
12/14/2011	CN102276717A 使用羟磷灰石层析除去高分子量聚集体 Using hydroxyapatite chromatography to remove high molecular weight aggregates
12/14/2011	CN102002480B 抗h3n2猪流感病毒血凝素蛋白单克隆抗体，杂交瘤细胞株及抗原捕获elisa试剂盒 Anti-h3n2 swine flu virus hemagglutinin protein monoclonal antibodies, hybridoma cell lines and antigen capture elisa kit
12/14/2011	CN101379184B 新颖的氧化还原酶及其用途 Novel oxidoreductase and use thereof
12/14/2011	CN101102791B 抗血管内皮生长因子受体-1的抗体 Anti-vascular endothelial growth factor receptor-1 antibody
12/14/2011	CN101027322B 促红细胞生成素受体结合抗体 Erythropoietin receptor antibody
12/13/2011	US8077851 Personal-call and feature control system and method for controlling telephones, providing extended features for such telephones and routing of media-rich calls
12/13/2011	US8076461 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids
12/13/2011	US8076460 Antibody and inhibitor, and transfection method or kit using them
12/13/2011	US8076459 Multispecfic deimmunized CD3-binders
12/13/2011	US8076458 Anti-claudin-4 antibody
12/13/2011	US8076456 Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof
12/13/2011	US8076286 Antimicrobial peptides and use thereof
12/13/2011	US8076091 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof
12/13/2011	US8076089 Biomarkers for liver diseases and method for using the same
12/13/2011	US8076066 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy
12/13/2011	US8075900 Melanoma associated peptide analogues and vaccines against melanoma
12/13/2011	US8075898 Mite allergen
12/13/2011	US8075897 Allergen peptide fragments and use thereof
12/13/2011	US8075893 Pharmaceutical composition of F(ab′)2 antibody fragments and a process for the preparation thereof
12/13/2011	US8075892 Treatment with anti-ErbB2 antibodies
12/13/2011	US8075890 Method for making humanized antibodies
12/13/2011	US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/13/2011	US8075884 Antibodies to OX-2/CD200 and uses thereof
12/13/2011	CA2495795C Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
12/13/2011	CA2475821C Group b streptococcus antigens
12/13/2011	CA2470743C Corticotropin releasing factor 2 receptor agonists
12/13/2011	CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances

1 ... 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 ... 1494